Clinical Trials Browser

Withdrawn × Interventional × Squamous NSCLC × Clear all

NCT07073183 2026-05-29

Safety and Tolerability of CVHNLC Plus Pembrolizumab in Patients With Squamous Non Small-Cell Lung Cancer (sqNSCLC)

Phase 1 Withdrawn

Squamous NSCLC